hr 1843In CommitteeHouseHealth
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
119th Congress·Introduced March 5, 2025·Last action March 5, 2025
A bill originating in the House that, if passed by both chambers and signed by the President, becomes law.